Related Experiment Videos
Seemingly diverse activities of beta-alethine
G D Knight1, P L Mann, K H Laubscher
1School of Medicine, University of New Mexico, Albuquerque 87131.
Cancer Research
|November 1, 1994
Summary
Beta-alethine significantly enhances cell adaptation, delays aging in human fibroblasts, and boosts immune cell activity. This compound shows promise in treating certain cancers, particularly myeloma, by improving cellular function.
Area of Science:
- Biochemistry
- Cell Biology
- Immunology
Background:
- Beta-alethine (beta-alanyl-cysteamine disulfide) possesses diverse biological activities.
- Previous research suggests potential therapeutic applications for compounds with similar structural features.
Purpose of the Study:
- To investigate the biological activities of beta-alethine in various cellular and animal models.
- To assess the potential of beta-alethine in treating specific types of neoplasia.
Main Methods:
- Cell culture experiments with murine liver cells and human IMR-90 fetal lung fibroblasts.
- Immunological assays using murine splenocytes and human peripheral blood leukocytes.
- In vivo studies utilizing syngeneic (NS-1 myeloma) and allogeneic (Cloudman S-91 melanoma) murine tumor models.
Main Results:
- Beta-alethine adapted murine liver cells to culture and delayed aging in human fibroblasts, significantly increasing cell population doublings and biomass.
- It markedly stimulated antibody-producing cells in both murine and human immune systems.
- Early intervention with beta-alethine successfully treated NS-1 myeloma in mice, though it was ineffective against Cloudman S-91 melanoma.
Conclusions:
- Beta-alethine enhances cellular phenotypic expression, function, and vitality across diverse biological systems.
- The compound demonstrates potential for treating certain types of neoplasia, particularly myeloma.
- The amide moieties in beta-alethine may be crucial for its potency and low toxicity.